- Home
- CLEU vs CSTL Comparison
CLEU vs CSTL Comparison
Compare CLEU & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLEU
- CSTL
- Stock Information
- Founded
- CLEU 2011
- CSTL 2007
- Country
- CLEU China
- CSTL United States
- Employees
- CLEU N/A
- CSTL N/A
- Industry
- CLEU Other Consumer Services
- CSTL Medical Specialities
- Sector
- CLEU Real Estate
- CSTL Health Care
- Exchange
- CLEU Nasdaq
- CSTL Nasdaq
- Market Cap
- CLEU 1.0B
- CSTL 848.1M
- IPO Year
- CLEU 2020
- CSTL 2019
- Fundamental
- Price
- CLEU $5.01
- CSTL $24.94
- Analyst Decision
- CLEU
- CSTL Strong Buy
- Analyst Count
- CLEU 0
- CSTL 6
- Target Price
- CLEU N/A
- CSTL $40.33
- AVG Volume (30 Days)
- CLEU 756.5K
- CSTL 434.0K
- Earning Date
- CLEU 10-11-2024
- CSTL 02-26-2025
- Dividend Yield
- CLEU N/A
- CSTL N/A
- EPS Growth
- CLEU N/A
- CSTL N/A
- EPS
- CLEU N/A
- CSTL 0.21
- Revenue
- CLEU $2,413,409.00
- CSTL $311,878,000.00
- Revenue This Year
- CLEU N/A
- CSTL $51.29
- Revenue Next Year
- CLEU N/A
- CSTL N/A
- P/E Ratio
- CLEU N/A
- CSTL $118.55
- Revenue Growth
- CLEU N/A
- CSTL 62.43
- 52 Week Low
- CLEU $0.12
- CSTL $16.97
- 52 Week High
- CLEU $5.53
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- CLEU 75.27
- CSTL 36.58
- Support Level
- CLEU $3.28
- CSTL $23.95
- Resistance Level
- CLEU $5.53
- CSTL $26.52
- Average True Range (ATR)
- CLEU 0.83
- CSTL 2.08
- MACD
- CLEU 0.10
- CSTL -0.36
- Stochastic Oscillator
- CLEU 79.37
- CSTL 11.26
About CLEU China Liberal Education Holdings Limited
China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.